Revolutionising precision oncology: new biomarker identification with 1-day NGS
Biomarker testing in precision oncology: a European revolution
Even in these hard times, our thought leaders virtually presented their experiences with our Oncomine™ NGS solutions in the most important European national pathology congresses. Have you missed the opportunity to join us in one of our satellite symposia during 2021?
Now you have the possibility to access all our on-demand content in local language and discover how NGS can be as fast and easy as IHC allowing your lab to test latest and established relevant biomarkers in a single day.
Choose the topic you are interested the most to learn more on:
Discover how to deliver NGS results at the same time as other single-gene methods with the Ion Torrent™ Genexus™ System.
Prof. Fernando Lopez-Rios, Universidad CEU San Pablo, Spain
Prof. Xavier Hernandez Losa, Vall d'Hebron University Hospital, Spain
Prof. Michael Hummel, Charité CCC, Germany
Dr. Hana Lango Allen, East Genomic Laboratory Hub, UK
Dr. Reiltin Werner, Cork University Hospital, Ireland
Dr. Annarita Destro, Humanitas Research Hospital, Italy
Dr. Javier Hernandez Losa, Director of Molecular Biology Laboratory, Pathology Department, Vall d'Hebron University Hospital, Spain
Dr. Paul Hofman, MD, PhD, Laboratory of Clinical and Experimental Pathology, Louis Pasteur Hospital, Nice, France
Listen to European oncologists and learn from them how NGS based molecular characterisation of tumour samples will provide a rational and highly promising approach for guiding oncologists in treatment decision-making.
Prof. Mariano Provencio, Hospital Universitario Puerta de Hierro, Spain
Prof. Mariano Provencio, Hospital Universitario Puerta de Hierro, Spain
Dr. Francesco Passiglia, University of Turin, Italy
Dr. Carlo Genova, Ospedale Policlinico San Martino, Italy
Dr. Damian Rieke, Charité – Universitätsmedizin Berlin, Germany
Gain more detailed insights faster with the complete Oncomine solid tumour NGS workflow solution. Listen to our users and discover our broad assay menu from targeted to comprehensive genomic profiling, with the smallest sample input requirements in the industry. Learn from them how to analyse more samples and produce complete bioinformatic reports that drive key insights.
Dr. Yolanda Ruano Dominguez, Hospital 12 de Octubre, Spain
Dr. Ines Raineri, Institute for Pathology Medica AG, Switzerland
Dr. Andreas Jung, University of Munich, Germany
Prof. Dr. Peter Wild, Universitätsklinikum Frankfurt, Germany
Dr. Massimo Barberis, Istituto Europeo di Oncologia, Italy
Dr. Nicola Normanno, Director of Department of Experimental Oncology, INT-Fondazione Pascale, Naples, Italy
Prof. Dr. Peter Wild, Director of Dr. Senckenberg Institute for Pathology, University Hospital Frankfurt, Germany
Dr. Jose Luis Costa, EMEA Medical Affairs Director,
Thermo Fisher Scientific
Dr. Massimo Barberis, Director of Histopathology and Molecular Diagnostics Unit, European Institute of Oncology, Italy
Ilaria Alborelli, PhD, Clinical Data Analyst, Institute of Pathology and Medical Genetics, University Hospital Basel, Switzerland
For Research Use only. Not for use in diagnostic procedures.
We've detected your location to be Japan.
Sorry, you cannot access this website. The content on www.oncomine.com is only intended for healthcare professionals. Formore information on our research solutions, please visit ThermoFisher.com
このウェブサイトは、日本国内の医療関係者の方への情報提供を目的としており、一般の方に対する情報提供を目的としたものではないことをご了承ください。研究用製品の情報はThermoFisher.comよりご覧ください。